TPWA
PCRX icon

TRUE Private Wealth Advisors’s Pacira BioSciences PCRX Stock Holding History

TRUE Private Wealth Advisors’s Portfolio PCRX Stock Details PCRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-140
Closed -$6.88K – 722
2018
Q3 		$6.88K Buy
+140
New +$6.05K ﹤0.01% 831

Other funds holding PCRX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
HM
HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
SIMG
Stephens Investment Management Group Houston, Texas $7.3B AUM 41.96% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

TRUE Private Wealth Advisors's PCRX Position: Q4 2018 in Review

TRUE Private Wealth Advisors sold out of Pacira BioSciences (PCRX) in Q4 2018, closing a stake of 140 shares — an estimated $6.88K sold.

TRUE Private Wealth Advisors first reported a position in PCRX in Q3 2018 and held it in 1 quarter. The position peaked at $6.88K in Q3 2018. 208 funds tracked by Wall St. Rank hold PCRX as of Q4 2018.

  • TRUE Private Wealth Advisors reported no remaining Pacira BioSciences position as of Q4 2018 after selling out during the quarter.
  • TRUE Private Wealth Advisors sold 140 Pacira BioSciences shares in Q4 2018, an estimated $6.88K.
  • TRUE Private Wealth Advisors first reported a position in Pacira BioSciences in Q3 2018 and held it in 1 quarter.
  • TRUE Private Wealth Advisors's Pacira BioSciences position peaked at $6.88K in Q3 2018.
  • 208 funds tracked by Wall St. Rank held Pacira BioSciences as of Q4 2018.

Based on TRUE Private Wealth Advisors's 13F filing for Q4 2018, filed 14 Jan 2019.